Connect Biopharma Hldgs (NASDAQ:CNTB) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.27) by 14.81 percent. This is a 34.78 percent decrease over losses of $(0.23) per share from the same period last year. The company reported $16.000 thousand in sales this quarter. This is a 98.69 percent decrease over sales of $1.219 million the same period last year.